255 related articles for article (PubMed ID: 31062422)
1. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
2. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
Zhu B; Ferry CH; Markell LK; Blazanin N; Glick AB; Gonzalez FJ; Peters JM
J Biol Chem; 2014 Jul; 289(29):20102-19. PubMed ID: 24898257
[TBL] [Abstract][Full Text] [Related]
3. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
5. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.
Montagner A; Delgado MB; Tallichet-Blanc C; Chan JS; Sng MK; Mottaz H; Degueurce G; Lippi Y; Moret C; Baruchet M; Antsiferova M; Werner S; Hohl D; Saati TA; Farmer PJ; Tan NS; Michalik L; Wahli W
EMBO Mol Med; 2014 Jan; 6(1):80-98. PubMed ID: 24203162
[TBL] [Abstract][Full Text] [Related]
6. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
Di-Poï N; Desvergne B; Michalik L; Wahli W
J Biol Chem; 2005 Nov; 280(46):38700-10. PubMed ID: 16166081
[TBL] [Abstract][Full Text] [Related]
8. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
[TBL] [Abstract][Full Text] [Related]
9. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
10. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
11. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
Zhu B; Ferry CH; Blazanin N; Bility MT; Khozoie C; Kang BH; Glick AB; Gonzalez FJ; Peters JM
Oncogene; 2014 Nov; 33(46):5348-59. PubMed ID: 24213576
[TBL] [Abstract][Full Text] [Related]
12. Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing.
Chong HC; Tan MJ; Philippe V; Tan SH; Tan CK; Ku CW; Goh YY; Wahli W; Michalik L; Tan NS
J Cell Biol; 2009 Mar; 184(6):817-31. PubMed ID: 19307598
[TBL] [Abstract][Full Text] [Related]
13. Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease.
Montagner A; Wahli W
Biomol Concepts; 2013 Feb; 4(1):53-64. PubMed ID: 25436565
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activity.
Bonala S; Lokireddy S; Arigela H; Teng S; Wahli W; Sharma M; McFarlane C; Kambadur R
J Biol Chem; 2012 Apr; 287(16):12935-51. PubMed ID: 22362769
[TBL] [Abstract][Full Text] [Related]
15. A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Genovese S; Foreman JE; Borland MG; Epifano F; Gonzalez FJ; Curini M; Peters JM
Life Sci; 2010 Mar; 86(13-14):493-8. PubMed ID: 20153754
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
[TBL] [Abstract][Full Text] [Related]
17. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice.
Tan MWY; Sng MK; Cheng HS; Low ZS; Leong BJJ; Chua D; Tan EHP; Chan JSK; Yip YS; Lee YH; Pal M; Wang X; Wahli W; Tan NS
Cell Death Differ; 2020 Sep; 27(9):2668-2680. PubMed ID: 32313198
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
